Proteomics

Dataset Information

0

Proteomic analysis of vascular tissue from critical limb ischemia mouse models treated with Etrinabdione


ABSTRACT: Vasculogenic therapies have been investigated for the treatment of peripheral artery disease (PAD) with very limited success in clinical trials. The isoform PP2A (protein phosphatase 2)/B55alpha inhibits the activity of the prolyl hydroxylase 2 (PHD2) and activates the hypoxia inducing factor-1alpha (HIF-1alpha), playing a key role in in vessel remodeling. Thus, PP2A/B55alpha activators may have the potential to induce angiogenesis and arteriogenesis. Herein we investigated the pharmacological attributes of VCE-004.8 (Etrinabdione) and its effectiveness in a murine model of critical limb ischemia.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Vascular Tissue

DISEASE(S): Peripheral Artery Disease

SUBMITTER: Martin Garrido  

LAB HEAD: Eduardo Muñoz

PROVIDER: PXD050360 | Pride | 2024-04-03

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2025-08-05 | PXD061045 | Pride
2024-12-02 | PXD056392 | Pride
2025-05-23 | PXD057989 | Pride
2025-05-07 | PXD053879 | Pride
2025-09-15 | PXD058098 | Pride
2025-09-29 | PXD057460 | Pride
2025-09-18 | PXD066110 | Pride
2025-06-10 | PXD050329 | Pride
2025-07-14 | PXD059015 | Pride
2025-07-21 | PXD049374 | Pride